Shin Nippon Biomedical Laboratories Ltd YB3-FF:Frankfurt Stock Exchange

RT Quote | Exchange | EUR
Last | 05/07/21 CEST
5.35quote price arrow down-0.05 (-0.93%)
52 week range
4.68 - 6.65

...

Loading . . .
  • Open5.35
  • Day High5.35
  • Day Low5.35
  • Prev Close5.40
  • 52 Week High6.65
  • 52 Week High Date09/16/20
  • 52 Week Low4.68
  • 52 Week Low Date03/04/21

Key Stats

  • Market Cap276.15M
  • Shares Out41.63M
  • 10 Day Average Volume-
  • Dividend0.04
  • Dividend Yield0.75%
  • Beta
  • YTD % Change2.88

KEY STATS

  • Open5.35
  • Day High5.35
  • Day Low5.35
  • Prev Close5.40
  • 52 Week High6.65
  • 52 Week High Date09/16/20
  • 52 Week Low4.68
  • 52 Week Low Date03/04/21
  • Market Cap276.15M
  • Shares Out41.63M
  • 10 Day Average Volume-
  • Dividend0.04
  • Dividend Yield0.75%
  • Beta
  • YTD % Change2.88

RATIOS/PROFITABILITY

  • EPS (TTM)0.46
  • P/E (TTM)11.63
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date03/30/2020
  • Div Amount5.00
  • Split Date-
  • Split Factor-

Latest On Shin Nippon Biomedical Laboratories Ltd

There is no recent news for this security.

Latest From Our Partners

There is no recent news for this security.

Profile

MORE
SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. is a Japan-based company mainly engaged in the provision of clinical trials and drug development services for pharmaceutical companies. The Company has four business segments. The Preclinical segment is engaged in the verification of the effectiveness and safety of new drugs by conducting tests on experimental animals, cells and bacteria. The Clinical segment is engaged in the verification of the effectiveness and safety of test...
Ryoichi Nagata
Chairman
Koichiro Fukuzaki
Vice Chairman
Ken Takanashi CPA
Chief Operating Officer
Address
28F, St Luke's Tower, 8-1, Akashi-cho
Chuo-ku, TKY
104-0044
Japan